TABLE 2.

MRSA infections and outcomes in 48 LT recipients

VariablePatients infected or colonized witha:P
hGISAb (n = 13)GSSAc (n = 35)
Infection/colonization ratio10/330/5NSb
Time of onset (days) of MRSA infectionNS
    0-146/10 (60)19/30 (63)
    14-303/10 (30)6/30 (20)
    >301/10 (10)5/30 (17)
Site of infectionNS
    Lower respiratory tract6/10 (60)11/30 (37)
    Abdomen4/10 (40)7/30 (23)
    Wound3/10 (30)12/30 (40)
    Intravascular device1/10 (10)5/30 (17)
    Other01/30 (3)
Bacteremia3/10 (30)11/30 (37)NS
Overall mortality1/13 (7.7)6/35 (17)NS
MRSA-related mortality1/13 (7.7)2/35 (5.7)NS
Mean duration (days [range]) of glycopeptide treatmentc18.5 (9-36)16 (7-56)NS
  • a Data are number of patients to which the variable applies per total number of patients in the group (percent), unless otherwise indicated.

  • b NS, nonsignificant.

  • c Data were analyzed for surviving patients only.